Global Human Milk Oligosaccharides (HMO) Market

Global Human Milk Oligosaccharides (HMO) Market Size, Share, Growth Analysis, By Type(2'-FL & 3-FL, Sialyllactose), By Application(Segmented as, Infant Formula) - Industry Forecast 2024-2031


Report ID: SQMIG30I2309 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 65 | Figures: 75

Global Human Milk Oligosaccharides (HMO) Market Insights

Global Human Milk Oligosaccharides (HMO) Market size was valued at USD 177.91 Million in 2022 and is poised to grow from USD 195.17 Million in 2023 to USD 409.32 Million by 2031, at a CAGR of 9.7% during the forecast period (2024-2031). 

The human milk oligosaccharides (HMO) market is becoming progressively more well-known as a vital element of the wellness and nutrition of infants. HMOs, or complex carbohydrates, are found naturally in human breast milk and are known to offer a variety of health advantages. These bioactive substances support the maturation of the infant's immune system, gastrointestinal health, and cognitive abilities. As our understanding of HMOs grows, there are more and more potential uses for them outside of baby nutrition, as in the fields of medicines, functional foods, and prebiotic supplements.

Growing public knowledge of HMOs' health benefits and the goal of making infant formula more like breast milk are the main factors driving market expansion. The capacity of HMOs to promote immunological and gut health is consistent with the growing trend of looking for natural and comprehensive remedies. The identification and creation of unique HMO arrangements to target distinct health advantages is another area of study attention.

However, challenges include the complexity and cost of HMO production, especially when replicating the diverse array of HMOs found in breast milk. Regulatory considerations and potential intellectual property hurdles also impact market dynamics. As HMO research continues to evolve, the market holds promise not only for infant nutrition but also for addressing various health concerns across the lifecycle. The potential to revolutionize the concept of nutrition and wellbeing underscores the significance of the HMO market in shaping the future of healthcare and functional foods.

US Human Milk Oligosaccharides (HMO) Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2024-2031

Global Market Size

USD 177.91 Million

Largest Segment

2'-FL & 3-FL

Fastest Growth

2'-FL & 3-FL

Growth Rate

9.7% CAGR

Global Human milk oligosaccharides (hmo) market ($ Bn)
Country Share for North America Region (%)
Global Human milk oligosaccharides (hmo) market By Type ($ Bn)
Global Human milk oligosaccharides (hmo) market By Type (%)

To get more reports on the above market click here to Buy The Report

Global Human Milk Oligosaccharides (HMO) Market Segmental Analysis

The Human Milk Oligosaccharides (HMO) Market is segmented on the basis of Type, Application, and Region. Based on Type, the market is segmented as, 2'-FL & 3-FL, Sialyllactose, LNT & LNnT. Based on Application the market is segmented as, Infant Formula, Functional Food & Beverages, Food/Medical Supplements, Others. Regional the market is segmented as, North America, Asia Pacific, Latin America, and Middle East & Africa (MEA)

Human Milk Oligosaccharides Market Analysis By Product

In human milk oligosaccharides (HMOs), the segment dominated by “2'-FL (2'-Fucosyllactose) and 3-FL (3-Fucosyllactose)” dominating the market. These HMOs are naturally abundant in human breast milk and have been extensively studied for their prebiotic and immune-supporting properties. The dominance of 2'-FL and 3-FL is attributed to their prevalence in breast milk and their potential to promote a healthy gut microbiome and contribute to infant immune development.

Simultaneously, the Sialyllactose segment is witnessing rapid growth and is considered the fastest-growing segment in the HMO market. Sialyllactose plays a crucial role in supporting brain development and cognitive function, making it an area of significant research interest. As scientific understanding advances, the demand for Sialyllactose-based products in infant formula and functional foods is on the rise, contributing to the segment's rapid growth.

Human Milk Oligosaccharides Market Analysis By Application

Within the category of human milk oligosaccharides (HMOs), the "Infant Formula" sector is the most prevalent. In order to support a newborn's general growth, immune system development, and gastrointestinal health, infant formula manufacturers are looking for HMOs that can replicate the positive effects of natural breast milk. The rising popularity of infant formula that contains HMOs is a major factor in the expansion of the HMO industry, as more parents are looking for the best nutrition possible for their infants.

In addition, the "Functional Food & Beverages" category is showing the fastest rate of growth. Beyond newborn nutrition, adult consumers seeking out functional foods that boost immunity and intestinal health are becoming more aware of the health benefits of HMOs. The potential for incorporating HMOs into a variety of functional foods and beverages is promising as research on their many health-promoting qualities continues to be discovered. The functional food and beverage industry is poised for strong growth within the HMO market, as consumers demonstrate an increasing interest in natural ingredients and holistic well-being.

Global Human milk oligosaccharides (hmo) market By Type, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Global Human Milk Oligosaccharides (HMO) Market Regional Insights

The human milk oligosaccharides (HMO) market showed notable regional variations, with North America having the largest market share. North America's advanced baby feeding business, robust research capacity, and increasing consumer demand for HMO-fortified goods are the reasons for its dominance. The notable use of HMOs in infant formula and related products can be attributed to the region's focus on ensuring optimal infant health and development.

Europe is now the second-biggest market for HMOs, after North America. Similar emphasis on infant health and nourishment, along with a pro-active regulatory structure that encourages the entry of new ingredients into the food and beverage industry, are advantageous for the European market. The use of HMOs in baby formula and other applications has been further supported by European consumers' preference for useful and health-improving products.

Global Human milk oligosaccharides (hmo) market By Geography, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Human Milk Oligosaccharides (HMO) Market Dynamics

Human Milk Oligosaccharides Market Drivers

Growing Awareness of Health Benefits:

  • The growing awareness of the advantages of human milk oligosaccharides (HMOs) for health is an important driver . Demand for HMO-fortified goods has increased as a result of the role that HMOs play in promoting the immune system, cognitive development, and gut health of infants as well as possible benefits for adults.

Rising Demand for Infant Nutrition:

  • The use of HMOs in formula products is a result of consumer desire for infant formula that closely resembles the health benefits of breast milk. HMOs have become a crucial component of baby nutrition as a result of parents wanting to give their babies the best possible nutrition.

Human Milk Oligosaccharides Market Restraints

Complex Production Process:

  • HMO synthesis is a difficult and complex process. Scalability and cost-effectiveness of HMO manufacturing are impacted by the complex and costly procedures needed to replicate the wide range of HMO structures present in breast milk.

Consumer Education:

  • Customers need to be made aware of the advantages and significance of HMOs, particularly when it comes to non-infant uses. It can be difficult, but increasing knowledge and awareness of the possibilities of HMOs is crucial for the market to expand.

Request Free Customization of this report to help us to meet your business objectives.

Global Human Milk Oligosaccharides (HMO) Market Competitive Landscape

The human milk oligosaccharides (HMO) market is very competitive, with both well-established manufacturers and creative entrants vying for market share as demand for HMO-fortified products rises. Prominent competitors include DuPont Nutrition & Biosciences, Nestlé S.A., Glycosyn LLC, Jennewein Biotechnologie GmbH, and Elicityl owing to their experience producing HMOs, their capacity for extensive research, and their established relationships in the infant nutrition and functional foods industries.

Human Milk Oligosaccharides Market Top Player’s Company Profile

  • Nestlé S.A.
  • Glycosyn LLC
  • Jennewein Biotechnologie GmbH
  • Inbiose
  • ZuChem Inc.
  • TMO Renewables Ltd.
  • Abbott Laboratories
  • Evolve Biosystems
  • Quantum Biotechnologies Inc.
  • Novalac
  • ZuChem Inc.
  • Clasado Biosciences
  • Metabiotics Corporation
  • Medolac Laboratories
  • HMO Research GmbH
  • Jennewein Biotechnologie
  • Holton BioSystems

Human Milk Oligosaccharides Market Recent Developments

  • In January 2023, Danone declared that a new baby formula enhanced with HMOs would be available. The product, Aptamil Pronutra HA, is intended to support an infant's immune system and intestinal health.
  • In February 2023, Nestlé declared that a new baby formula enhanced with HMOs would be available. Nido FortifiGrow+, the formula, is intended to assist newborns' intellectual growth.
  • In March 2023, A study that was written up in the journal "Nature" suggested that HMOs might aid in defending newborns against respiratory illnesses. According to the study, babies who were given formula supplemented with HMOs had a lower risk of respiratory infections than babies who were given formula without HMOs.
  • In April 2023, A study in the journal "Pediatrics" discovered that HMOs might assist in enhancing the gut microbiota of newborns. According to the study, babies who were given formula with HMOs added to it had a more balanced and diversified gut microbiota than babies who were given formula without HMOs.

Global Human Milk Oligosaccharides (HMO) Key Market Trends

  • Expanding Applications Beyond Infant Nutrition: Although HMOs have historically been linked to baby feeding and are found naturally in breast milk, there is a rising movement to investigate their potential in other contexts. HMOs are being researched for use in functional foods, dietary supplements, and even medications to treat a range of health issues in people of different ages.
  • Customization and HMO Profiling: An increasing number of HMO profiles are being created that closely resemble the breast milk of specific moms as scientific knowledge of HMOs grows. Because each mother's milk has a different HMO composition, this tailoring gives the possibility of providing newborns with individualized nutrition.

Global Human Milk Oligosaccharides (HMO) Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Component types team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our Global Human Milk Oligosaccharides (HMO) Market analysis; the human milk oligosaccharides (HMO) market is experiencing significant growth globally, driven by increasing awareness of HMOs' health benefits. The market spans across regions, with North America and Europe leading due to their advanced infant nutrition sectors. Segments include infant formula, functional food and beverages, and dietary supplements. The dominance of the infant formula segment stems from the demand for breast milk mimicking nutrition. The functional food and beverage segment is emerging rapidly as consumers seek natural ingredients promoting gut health and immunity. Key drivers include rising consumer demand for holistic health solutions, ongoing research unveiling diverse HMO benefits, and collaborations fostering innovation in HMO applications. As industries embrace HMOs for their potential beyond infant nutrition, the market is poised for continued expansion and innovation.

Report Metric Details
Market size value in 2023 USD 177.91 Million
Market size value in 2031 USD 409.32 Million
Growth Rate 9.7%
Forecast period 2024-2031
Forecast Unit (Value) USD Million
Segments covered
  • Type
    • 2'-FL & 3-FL, Sialyllactose, LNT & LNnT
  • Application
    • Segmented as, Infant Formula, Functional Food & Beverages, Food/Medical Supplements, and Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Nestlé S.A.
  • Glycosyn LLC
  • Jennewein Biotechnologie GmbH
  • Inbiose
  • ZuChem Inc.
  • TMO Renewables Ltd.
  • Abbott Laboratories
  • Evolve Biosystems
  • Quantum Biotechnologies Inc.
  • Novalac
  • ZuChem Inc.
  • Clasado Biosciences
  • Metabiotics Corporation
  • Medolac Laboratories
  • HMO Research GmbH
  • Jennewein Biotechnologie
  • Holton BioSystems
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Human Milk Oligosaccharides (HMO) Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Human Milk Oligosaccharides (HMO) Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Human Milk Oligosaccharides (HMO) Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Human Milk Oligosaccharides (HMO) Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Human Milk Oligosaccharides (HMO) Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Human Milk Oligosaccharides (HMO) Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Human Milk Oligosaccharides (HMO) Market size was valued at USD 177.91 Million in 2022 and is poised to grow from USD 195.17 Million in 2023 to USD 409.32 Million by 2031, at a CAGR of 9.7% during the forecast period (2024-2031). 

The human milk oligosaccharides (HMO) market is very competitive, with both well-established manufacturers and creative entrants vying for market share as demand for HMO-fortified products rises. Prominent competitors include DuPont Nutrition & Biosciences, Nestlé S.A., Glycosyn LLC, Jennewein Biotechnologie GmbH, and Elicityl owing to their experience producing HMOs, their capacity for extensive research, and their established relationships in the infant nutrition and functional foods industries. 'DuPont Nutrition & Biosciences', 'Nestlé S.A.', 'Glycosyn LLC', 'Jennewein Biotechnologie GmbH', 'Elicityl', 'Inbiose', 'ZuChem Inc.', 'Glycom A/S', 'TMO Renewables Ltd.', 'Abbott Laboratories', 'Evolve Biosystems', 'Quantum Biotechnologies Inc.', 'Novalac', 'ZuChem Inc.', 'Clasado Biosciences', 'Metabiotics Corporation', 'Medolac Laboratories', 'HMO Research GmbH', 'Jennewein Biotechnologie', 'Holton BioSystems'

The growing awareness of the advantages of human milk oligosaccharides (HMOs) for health is an important driver . Demand for HMO-fortified goods has increased as a result of the role that HMOs play in promoting the immune system, cognitive development, and gut health of infants as well as possible benefits for adults.

Expanding Applications Beyond Infant Nutrition: Although HMOs have historically been linked to baby feeding and are found naturally in breast milk, there is a rising movement to investigate their potential in other contexts. HMOs are being researched for use in functional foods, dietary supplements, and even medications to treat a range of health issues in people of different ages.

The human milk oligosaccharides (HMO) market showed notable regional variations, with North America having the largest market share. North America's advanced baby feeding business, robust research capacity, and increasing consumer demand for HMO-fortified goods are the reasons for its dominance. The notable use of HMOs in infant formula and related products can be attributed to the region's focus on ensuring optimal infant health and development.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Human Milk Oligosaccharides (HMO) Market

Product ID: SQMIG30I2309

$5,300
BUY NOW GET FREE SAMPLE